Tories would scrap NHS database plans
August 11, 2009NHS, digi, healthcare
The Conservatives have pledged to scrap the government's plans for a central database of patient records, in order to save …
Sticky or stuck?
August 11, 2009Medical Communications doctors, social networking
The 60's philosopher and communications guru Marshall McLuhan said, "the medium is the message" and certainly the current buzz around …
Wyboston launches delegate guide to conference etiquette
August 11, 2009Medical Communications Conferences
Wyboston Lakes, one of the UK's best known conference and training centres, has launched a guide to help delegates make …
Skills council for pharma
August 11, 2009Research and Development, Sales and Marketing Jobs, training
The UK pharmaceutical sector is set to get its own body dedicated to identifying and addressing key skills issues. A …
Contract research news in brief
August 11, 2009Research and Development CRO, Omnicom
Pharmafocus presents its periodic round-up of developments in the contract research sector, including updates from Pharm-Olam, OmniComm, SIRO, Ecron Acunova …
Charles River cuts forecasts as profits slump
August 11, 2009Research and Development Charles River, preclinical
Contract preclinical testing specialist Charles River Laboratories saw its second-quarter sales drop 12.5% to $308 million as demand from pharmaceutical …
Sanofi submits FDA application for swine flu vaccine
August 10, 2009Research and Development, Sales and Marketing Sanofi-Aventis, h1n1
Sanofi Pasteur has filed with US regulators a supplemental license application for its vaccine to protect against the H1N1 pandemic …
Doubts about funding for ‘Innovation Pass’
August 10, 2009Research and Development, Sales and Marketing ABPI, NHS, NICE
The new fast-tracking system announced to help accelerate uptake of innovative new treatments in the UK, could be held back …
TNF blockers must carry children’s cancer warning
August 7, 2009Research and Development, Sales and Marketing FDA, RA, TNF
The FDA has ruled that TNF blocker drugs should carry new warnings of the increased risk of certain cancers for …
Vernalis and GSK sign risk-sharing deal
August 7, 2009Research and Development, Sales and Marketing Deals, GSK, Vernalis
Vernalis and GlaxoSmithKline have joined forces to work on a cancer treatment in a deal which could be worth more …
Pfizer agrees price cut in Clinton deal
August 7, 2009Research and Development, Sales and Marketing HIV, Pfizer, generics
Former US President Bill Clinton has brokered major new deals with Pfizer and Mylan to cut the price of tuberculosis …
Hobson Prior achieves new quality standard
August 7, 2009Business Services Hobson Prior
Recruitment specialists Hobson Prior has achieved the latest ISO Quality Standard: ISO 9001:2008. Founded in 2002, Hobson Prior specialises in …
Quintiles opens Ghana office
August 7, 2009Research and Development Africa, Quintiles
Quintiles has opened a new office in Accra, Ghana, which it says will increase capacity to manage clinical studies for …
Hugh Grant backs social media healthcare site
August 7, 2009Medical Communications, Sales and Marketing Digitial, patient information
The actor Hugh Grant is backing a new health advice website that encourages patients to share their experiences of illness. …
Racing to save lives and fighting the PR battle
August 6, 2009Medical Communications, Research and Development Vaccine, clinical trials, public relations
Vaccine companies are working round the clock to develop and manufacture a vaccine for the H1N1 pandemic flu, and are …
Vasella targeted by animal rights activists
August 6, 2009Research and Development, Sales and Marketing Animal tests, Novartis, Vasella
Animal rights activists are believed to be behind two attacks on Novartis chief executive Daniel Vasella. The first attack came …
Afinitor approved in EU
August 6, 2009Research and Development, Sales and Marketing Afinitor, Cancer, Europe, Novartis
Novartis’ new kidney cancer drug Afinitor (everolimus) has been approved in the EU for use when products such as Sutent …
US approval for Onglyza
August 6, 2009Research and Development, Sales and Marketing AZ, BMA, diabetes
Adult type II diabetes treatment Onglyza has been approved by the US Food and Drug Administration. Co-marketed by AstraZeneca and …
FDA blocks Teva from selling vet drugs and warns Apotex
August 6, 2009Manufacturing and Production Apotex, FDA, Teva
The FDA’s clampdown on quality standards continues apace, with Teva’s animal health unit in Missouri and an Apotex plant in …
Industry working group to look at UK digital marketing
August 6, 2009Medical Communications, Sales and Marketing digi, pm society
The PM Society has set up an industry working group to bring some much-needed clarity to the uncharted waters of …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
